Clinical Trial Update: Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical study of a targeted CD19/BCMA CAR-T therapy for autoimmune diseases is recruiting, including systemic lupus erythematosus and related condi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Idiopathic Inflammatory Myopathy
• Multiple Sclerosis
• Myasthenia Gravis
• Neuromyelitis Optica Spectrum Disorder
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• CD19/BCMA CAR-T therapy

Snippet

Sponsor: Nanjing Bioheng Biotech Co., Ltd. | Conditions: SLE, Systemic Sclerosis | EARLY_Phase 1 | Status: RECRUITING